"/> Novus Biologicals™ Peptide bloquant d’anticorps IR… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps IRGM

Réf. : BL-RE-050250Réf. fabricant : 18219095 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
345611
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76377. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 17 amino acids near the amino terminus of human IRGM.

Points forts

Source

Synthetic

(Accession #: AAI28169) The IRGM Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-050250
Réf. fabricant18219095
Gene ID (Entrez)345611
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76377. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneIFI1, immunity-related GTPase family M protein, immunity-related GTPase family, M, interferon-inducible protein 1, IRGM1, LPS-stimulated RAW 264.7 macrophage protein 47 homolog, LRG47, LRG-47, LRG-47-like protein, M1, MGC149263, MGC149264
Symbole de gène(s)IRGM
Type de produitIRGM
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne17 amino acids near the amino terminus of human IRGM
Une question, une configuration particulière ?
Contactez-nous pour un devis.